A detailed history of Degroof Petercam Asset Management transactions in Incyte Corp stock. As of the latest transaction made, Degroof Petercam Asset Management holds 3,862 shares of INCY stock, worth $276,982. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,862
Previous 3,862 -0.0%
Holding current value
$276,982
Previous $242 Million 9.27%
% of portfolio
0.0%
Previous 0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$52.16 - $64.19 $201,441 - $247,901
3,862 New
3,862 $242 Million

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $16B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Degroof Petercam Asset Management Portfolio

Follow Degroof Petercam Asset Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Degroof Petercam Asset Management, based on Form 13F filings with the SEC.

News

Stay updated on Degroof Petercam Asset Management with notifications on news.